Manning Meredith
Manning Meredith, DIR, reported a transaction classified as grant at Unicycive Therapeutics, Inc. involving 27000.000000 shares for an estimated $0.00. Reported holdings after the transaction were 27000.000000 shares. A 10b5-1 reference was not detected in the stored filing text.
- Trade date
- Oct 28, 2026
- Filing date
- Oct 29, 2026
How reported position traded is calculated
Not calculated for derivative securities.
Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.
UNCY price since this filing
Daily closing prices, with the filing date and available return windowsTransaction facts
Stored Form 4 columns with their raw values
- Type
- grant Code A
- Identifier
- 0001213900-26-113840 Stock Options
- Transaction date
- Oct 28, 2026 Filed Oct 29, 2026, 08:30 PM · 1d delay
- Shares
- 27,000 sh $0.00 per share
- Estimated value
- $0 Computed from shares × price
- Holdings after
- 27,000 sh Direct
Filing signal explanations
Badges describe filing facts only — not predictions.
-6 points
Compact filing score computed from stored Form 4 facts. Version v1.
This filing has a negative filing-only score. It may be less informative as an insider-activity signal and needs extra context.
How this score is calculated
- direct_ownership+6 points
direct_or_indirect_ownership = D
Direct ownership reports the insider's personal stake. - timely_filing+4 points
reporting_delay_days = 1
Filing reported within two business days of the transaction. - derivative_transaction-16 points
is_derivative = true
Derivative exercise rows are less discretionary than open-market purchases.
Signed filing-only points, not a probability or expected return. Version v1.
Reported relationships & other filings
Form 4 relationship flags and nearby filing context
No officer title
- F1
Represents grant of restricted stock units payable solely in common stock of the Issuer. 837 shares vest upon grant and 209 vest monthly over 12 months beginning Nov. 1, 2026, subject to the Reporting…
0 other transactions
0 recent txs